Study of ADCT-301 in Patients With Relapsed/Refractory CD25-positive Acute Myeloid Leukemia (AML) or CD25-positive Acute Lymphoblastic Leukemia (ALL)
Clinical trial NCT02588092 · TERMINATED
Trial details
- NCT number
- NCT02588092
- Sponsor
- ADC Therapeutics S.A.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2018-08-29
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.